Research and Policy CSR News

Alkermes Associate Director Shares How Cancer Motivates Her at Work

Multimedia with summary

Meet Lauren Sneider, Associate Director of Corporate Communications. Lauren shares how her experience with cancer makes her proud to work for a company that is continually researching potential new oncology treatment options.

Rediscovering Resilience

The COVID-19 pandemic will end. Our support for healthcare systems and patients won’t.
Article

The case for hope

International WELL Building Institute Launches Global Research Agenda

Call to action to drive timely and innovative global research linking buildings, organizations and communities with health and the human experience
Press Release

NEW YORK, January 26, 2021 /3BL Media/ – The International WELL Building Institute (IWBI) today announced the launch of its Global Research Agenda, an interdisciplinary global call to action to support innovative health and built environment research, to unite disciplines across the fields of health, well-being and the built environment, and to translate research into practice.

Ukko Secures USD 40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and Sensitivities

Top industry leaders and venture firms unite behind Ukko’s efforts to eliminate the world's most prevalent food allergies and sensitivities, including peanuts and gluten
Press Release

Palo Alto /Tel Aviv / Leverkusen, January 27, 2021 /3BL Media/ – Ukko, a biotech company with the mission to eliminate food allergies and sensitivities, today announced USD 40 million in new Series B funding. Ukko harnesses artificial intelligence (AI) and protein engineering to develop healthier food and therapies for food allergies. The new funding will allow Ukko to enter clinical trials with its investigational therapeutic for peanut allergies. It will also accelerate development of Ukko’s gluten that is designed for people with celiac and other gluten sensitivities.

Abbott's BinaxNOW, FreeStyle Libre 2 Win BIG Innovation Honors

At-home COVID-19 test, groundbreaking glucose monitoring system among Business Intelligence Group's best of 2021.
Blog

We promise, we're not going to make too big of a deal of winning any award. But this news is definitely two BIG to keep quiet about.

Children's Mental Health in the Time of COVID

Summary: 

The pandemic has exacerbated depression and anxiety, especially among children. A new Child Mind Institute survey supported by Morgan Stanley shows the depth and breadth of the problem.

Blog

The pandemic has exacerbated depression and anxiety, especially among children. A new Child Mind Institute survey supported by Morgan Stanley shows the depth and breadth of the problem.

Abbott Receives FDA 510(K) Clearance for the First Rapid Handheld Blood Test for Concussions

Summary: 
  • The test to help evaluate mild traumatic brain injury (TBI), commonly known as concussion, produces a result within 15 minutes after a plasma sample is inserted and will run on Abbott's i-STAT™ Alinity™ handheld device
  • Having a blood test available could help eliminate wait time in the emergency room and could reduce the number of unnecessary CT scans by up to 40%
  • The test simultaneously measures biomarkers UCH-L1 and GFAP, proteins found in the blood after a concussion or head trauma
  • Building on this initial clearance, Abbott is also working on a test that would use whole blood on i-STAT at the point of care, and developing a test for its Alinity™ i and ARCHITECT® core laboratory instruments under FDA breakthrough designation
Press Release
  • The test to help evaluate mild traumatic brain injury (TBI), commonly known as concussion, produces a result within 15 minutes after a plasma sample is inserted and will run on Abbott's i-STAT™ Alinity™ handheld device
  • Having a blood test available could help eliminate wait time in the emergency room and could reduce the number of unnecessary CT scans by up to 40%
  • The test simultaneously measures biomarkers UCH-L1 and GFAP, proteins found in the blood after a concussion or head trauma
  • Building on this initial clearance, Abbott is also working on a test that would use whole blood on i-STAT at the point of care, and developing a test for its Alinity™ i and ARCHITECT® core laboratory instruments under FDA breakthrough designation

CNH Industrial Supports a New Study by the Telethon Foundation Into the Virus That Causes COVID-19

Summary: 

As in previous years, CNH Industrial is supporting the Telethon Foundation by contributing to a targeted study on the ongoing pandemic. This involves a series of tests on the strain of the virus that causes COVID-19, with the aim of reconstructing its transmission tree.

Press Release

As in previous years, CNH Industrial is supporting the Telethon Foundation by contributing to a targeted study on the ongoing pandemic. This involves a series of tests on the strain of the virus that causes COVID-19, with the aim of reconstructing its transmission tree.

FDA Authorizes Ecolab's Bioquell Technology System for N95 Respirator Decontamination

Ecolab’s decontamination technology enables respirator reuse by healthcare personnel to help address shortages
Press Release

ST. PAUL, Minn. – December 18, 2020  /3BL Media/ – Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services that protect people and vital resources, has received Emergency Use Authorization (EUA) from the U.S.

How Ecolab Supports the COVID-19 Vaccine Race From Invention to Injection

Less than a year into the COVID-19 pandemic, pharmaceutical companies are beginning to roll out the first vaccines. Ecolab has provided vital support at every stage of the process.
Article

Since the emergence of COVID-19 nearly a year ago, pharmaceutical companies around the world have worked at unprecedented speeds to deliver an effective vaccine. The development of vaccines is a painstakingly complex process and the manufacturing scale—sufficient doses to protect all 7.5 billion people on Earth—is tremendous.

Pages

Subscribe to Research and Policy